Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.
Snigdha GulatiMohak GuptaTingTing YanSneha YelamanchiliLucy Qinghua XuTina BharaniAli NajiDivyansh AgarwalPublished in: PharmacoEconomics (2024)
This study underscores the significant potential for Medicare Part D savings through strategies that address the systemic overpayment for generic medications. We identified key areas for reform as well as specific medical and surgical subspecialties where targeted interventions could yield substantial savings.